5-Lipoxygenase inhibitors: a patent evaluation (WO2011161615)

Author： Buscató Estel.la   Proschak Ewgenij  

Publisher： Informa Healthcare

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.22, Iss.7, 2012-07, pp. : 843-846

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

5-Lipoxygenase inhibitors – patent and literature activity during 2001 – 2004

By Pommery Nicole   Massingham Roy   Hénichart Jean-Pierre  

Expert Opinion on Therapeutic Patents, Vol. 16, Iss. 1, 2006-01 ,pp. : 13-26

Informa Healthcare

Access to resources Recommend Favorite

Inhibitors of influenza viruses replication: a patent evaluation (WO2013019828)

By Xie Yuanchao   Song Weiguo   Xiao Weidong   Gu Changjuan   Xu Wenfang  

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 11, 2013-11 ,pp. : 1517-1524

Informa Healthcare

Access to resources Recommend Favorite

Pyrazolopyridines as inhibitors of the kinase LRRK2: a patent evaluation (WO2011141756)

By Deng Xianming   S. Gray Nathanael  

Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 6, 2012-06 ,pp. : 709-713

Informa Healthcare

Access to resources Recommend Favorite

Inhibitors of cyclooxygenase-2 and 5-lipoxygenase

By  

Expert Opinion on Therapeutic Patents, Vol. 7, Iss. 9, 1997-09 ,pp. : 1041-1042

Informa Healthcare

Access to resources Recommend Favorite

Recent developments in 5lipoxygenase inhibitors

By Julémont Fabien   Dogné Jean-Michel   Laeckmann Didier   Pirotte Bernard   Leval Xavier de  

Expert Opinion on Therapeutic Patents, Vol. 13, Iss. 1, 2003-01 ,pp. : 1-13

Informa Healthcare

Access to resources Recommend Favorite